Webb20 maj 2024 · Optimal, minimax and admissible two-stage design for phase II oncology clinical trials Whenever (p0, p1) is pre-specified, it is better to explore in the range of probability q, based on relative importance between maximum sample size and expected sample size, and determine which design to choose. WebbOptimal Two-Stage Designs for Phase II Clinical Trials; Integrated Phase II/III Study; Sample Size Planning for Developing Classifiers; Design, Monitoring and Analysis of Bayesian …
188-2007: Using SAS® to Determine Sample Sizes for Traditional Two …
Webb20 maj 2024 · In both Simon’s and Fleming’s two-stage designs, the maximum sample size of admissible design is smaller than optimal design but larger than minimax design. … Webbtwo-stage design that is optimal in the sense that the expected sample size is minimized if the regimen has low activity subject to constraints upon the size of the type 1 and type 2 errors. Two-stage designs which minimize the maximum sample size are also determined. simon2stage(p0, pa, alpha, beta, eps =0, N_min, N_max, int =0, citylight pincode
R: Simon
Webb22 feb. 2024 · In early phase clinical studies in oncology, Simon's two-stage designs are widely used. The trial design could be made more efficient by stopping early in the … Webb15 apr. 2024 · Design parameters. Type I error rate, α (one-sided): Power, 1-β : Unpromising response rate, p0 (null hypothesis) Desirable response rate, p1 (alternative hypothesis) … WebbA robust two-stage design identifying the optimal biological dose for phase I/II clinical trials. Stat Med 36(1):27-42, 1/2024. e-Pub 8/2016. PMCID: PMC5138134. did cher win her lawsuit against mary bono